They focused on the PDPN molecule that is specifically expressed in the human glioblastoma cell line LN229, which had a different glycosylation pattern compared to the normal cells, and thereafter established CasMab by transplanting LN229 cells expressing PDPN (LN229/hPDPN) into mice. Here, PDPN is linked to glioblastoma.